1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Benign Rolandic Epilepsy 1.2.3 Childhood Absence Epilepsy 1.2.4 Juvenile Myoclonic Epilepsy 1.2.5 Infantile Spasms 1.2.6 Lennox-Gastaut Syndrome 1.3 Market by Application 1.3.1 Global Pediatric Epilepsy Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Neurology Centers 1.3.4 Home Care Settings 1.3.5 Ambulatory Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pediatric Epilepsy Therapeutics Market Perspective (2016-2027) 2.2 Pediatric Epilepsy Therapeutics Growth Trends by Regions 2.2.1 Pediatric Epilepsy Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pediatric Epilepsy Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Pediatric Epilepsy Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Pediatric Epilepsy Therapeutics Industry Dynamic 2.3.1 Pediatric Epilepsy Therapeutics Market Trends 2.3.2 Pediatric Epilepsy Therapeutics Market Drivers 2.3.3 Pediatric Epilepsy Therapeutics Market Challenges 2.3.4 Pediatric Epilepsy Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pediatric Epilepsy Therapeutics Players by Revenue 3.1.1 Global Top Pediatric Epilepsy Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Pediatric Epilepsy Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Pediatric Epilepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pediatric Epilepsy Therapeutics Revenue 3.4 Global Pediatric Epilepsy Therapeutics Market Concentration Ratio 3.4.1 Global Pediatric Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pediatric Epilepsy Therapeutics Revenue in 2020 3.5 Pediatric Epilepsy Therapeutics Key Players Head office and Area Served 3.6 Key Players Pediatric Epilepsy Therapeutics Product Solution and Service 3.7 Date of Enter into Pediatric Epilepsy Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pediatric Epilepsy Therapeutics Breakdown Data by Type 4.1 Global Pediatric Epilepsy Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Type (2022-2027) 5 Pediatric Epilepsy Therapeutics Breakdown Data by Application 5.1 Global Pediatric Epilepsy Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pediatric Epilepsy Therapeutics Market Size (2016-2027) 6.2 North America Pediatric Epilepsy Therapeutics Market Size by Type 6.2.1 North America Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Pediatric Epilepsy Therapeutics Market Size by Type (2016-2027) 6.3 North America Pediatric Epilepsy Therapeutics Market Size by Application 6.3.1 North America Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Pediatric Epilepsy Therapeutics Market Size by Application (2016-2027) 6.4 North America Pediatric Epilepsy Therapeutics Market Size by Country 6.4.1 North America Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Pediatric Epilepsy Therapeutics Market Size (2016-2027) 7.2 Europe Pediatric Epilepsy Therapeutics Market Size by Type 7.2.1 Europe Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Pediatric Epilepsy Therapeutics Market Size by Type (2016-2027) 7.3 Europe Pediatric Epilepsy Therapeutics Market Size by Application 7.3.1 Europe Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Pediatric Epilepsy Therapeutics Market Size by Application (2016-2027) 7.4 Europe Pediatric Epilepsy Therapeutics Market Size by Country 7.4.1 Europe Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Type 8.2.1 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Application 8.3.1 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Region 8.4.1 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pediatric Epilepsy Therapeutics Market Size (2016-2027) 9.2 Latin America Pediatric Epilepsy Therapeutics Market Size by Type 9.2.1 Latin America Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Pediatric Epilepsy Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Pediatric Epilepsy Therapeutics Market Size by Application 9.3.1 Latin America Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Pediatric Epilepsy Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Pediatric Epilepsy Therapeutics Market Size by Country 9.4.1 Latin America Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Type 10.2.1 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Application 10.3.1 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Country 10.4.1 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Pediatric Epilepsy Therapeutics Introduction 11.1.4 Abbott Laboratories Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Details 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Pediatric Epilepsy Therapeutics Introduction 11.2.4 GlaxoSmithKline Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.2.5 GlaxoSmithKline Recent Development 11.3 Cephalon 11.3.1 Cephalon Company Details 11.3.2 Cephalon Business Overview 11.3.3 Cephalon Pediatric Epilepsy Therapeutics Introduction 11.3.4 Cephalon Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.3.5 Cephalon Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Pediatric Epilepsy Therapeutics Introduction 11.4.4 Pfizer Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 Novartis 11.5.1 Novartis Company Details 11.5.2 Novartis Business Overview 11.5.3 Novartis Pediatric Epilepsy Therapeutics Introduction 11.5.4 Novartis Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.5.5 Novartis Recent Development 11.6 Sunovion Pharmaceuticals 11.6.1 Sunovion Pharmaceuticals Company Details 11.6.2 Sunovion Pharmaceuticals Business Overview 11.6.3 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Introduction 11.6.4 Sunovion Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.6.5 Sunovion Pharmaceuticals Recent Development 11.7 Bausch Health 11.7.1 Bausch Health Company Details 11.7.2 Bausch Health Business Overview 11.7.3 Bausch Health Pediatric Epilepsy Therapeutics Introduction 11.7.4 Bausch Health Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.7.5 Bausch Health Recent Development 11.8 Sanofi 11.8.1 Sanofi Company Details 11.8.2 Sanofi Business Overview 11.8.3 Sanofi Pediatric Epilepsy Therapeutics Introduction 11.8.4 Sanofi Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) 11.8.5 Sanofi Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Benign Rolandic Epilepsy Table 3. Key Players of Childhood Absence Epilepsy Table 4. Key Players of Juvenile Myoclonic Epilepsy Table 5. Key Players of Infantile Spasms Table 6. Key Players of Lennox-Gastaut Syndrome Table 7. Global Pediatric Epilepsy Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Pediatric Epilepsy Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Pediatric Epilepsy Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Pediatric Epilepsy Therapeutics Market Share by Regions (2016-2021) Table 11. Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Pediatric Epilepsy Therapeutics Market Share by Regions (2022-2027) Table 13. Pediatric Epilepsy Therapeutics Market Trends Table 14. Pediatric Epilepsy Therapeutics Market Drivers Table 15. Pediatric Epilepsy Therapeutics Market Challenges Table 16. Pediatric Epilepsy Therapeutics Market Restraints Table 17. Global Pediatric Epilepsy Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Pediatric Epilepsy Therapeutics Market Share by Players (2016-2021) Table 19. Global Top Pediatric Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2020) Table 20. Ranking of Global Top Pediatric Epilepsy Therapeutics Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Pediatric Epilepsy Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Pediatric Epilepsy Therapeutics Product Solution and Service Table 24. Date of Enter into Pediatric Epilepsy Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 27. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2016-2021) Table 28. Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Pediatric Epilepsy Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2016-2021) Table 32. Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 35. North America Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 37. North America Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 64. Abbott Laboratories Company Details Table 65. Abbott Laboratories Business Overview Table 66. Abbott Laboratories Pediatric Epilepsy Therapeutics Product Table 67. Abbott Laboratories Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 68. Abbott Laboratories Recent Development Table 69. GlaxoSmithKline Company Details Table 70. GlaxoSmithKline Business Overview Table 71. GlaxoSmithKline Pediatric Epilepsy Therapeutics Product Table 72. GlaxoSmithKline Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 73. GlaxoSmithKline Recent Development Table 74. Cephalon Company Details Table 75. Cephalon Business Overview Table 76. Cephalon Pediatric Epilepsy Therapeutics Product Table 77. Cephalon Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 78. Cephalon Recent Development Table 79. Pfizer Company Details Table 80. Pfizer Business Overview Table 81. Pfizer Pediatric Epilepsy Therapeutics Product Table 82. Pfizer Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 83. Pfizer Recent Development Table 84. Novartis Company Details Table 85. Novartis Business Overview Table 86. Novartis Pediatric Epilepsy Therapeutics Product Table 87. Novartis Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 88. Novartis Recent Development Table 89. Sunovion Pharmaceuticals Company Details Table 90. Sunovion Pharmaceuticals Business Overview Table 91. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Product Table 92. Sunovion Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 93. Sunovion Pharmaceuticals Recent Development Table 94. Bausch Health Company Details Table 95. Bausch Health Business Overview Table 96. Bausch Health Pediatric Epilepsy Therapeutics Product Table 97. Bausch Health Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 98. Bausch Health Recent Development Table 99. Sanofi Company Details Table 100. Sanofi Business Overview Table 101. Sanofi Revenue in Pediatric Epilepsy Therapeutics Business (2016-2021) & (US$ Million) Table 102. Sanofi Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Pediatric Epilepsy Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Benign Rolandic Epilepsy Features Figure 3. Childhood Absence Epilepsy Features Figure 4. Juvenile Myoclonic Epilepsy Features Figure 5. Infantile Spasms Features Figure 6. Lennox-Gastaut Syndrome Features Figure 7. Global Pediatric Epilepsy Therapeutics Market Share by Application: 2020 VS 2027 Figure 8. Hospitals Case Studies Figure 9. Neurology Centers Case Studies Figure 10. Home Care Settings Case Studies Figure 11. Ambulatory Surgical Centers Case Studies Figure 12. Pediatric Epilepsy Therapeutics Report Years Considered Figure 13. Global Pediatric Epilepsy Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Pediatric Epilepsy Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Pediatric Epilepsy Therapeutics Market Share by Regions: 2020 VS 2027 Figure 16. Global Pediatric Epilepsy Therapeutics Market Share by Regions (2022-2027) Figure 17. Global Pediatric Epilepsy Therapeutics Market Share by Players in 2020 Figure 18. Global Top Pediatric Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Pediatric Epilepsy Therapeutics Revenue in 2020 Figure 20. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2016-2021) Figure 21. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2022-2027) Figure 22. North America Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Pediatric Epilepsy Therapeutics Market Share by Type (2016-2027) Figure 24. North America Pediatric Epilepsy Therapeutics Market Share by Application (2016-2027) Figure 25. North America Pediatric Epilepsy Therapeutics Market Share by Country (2016-2027) Figure 26. United States Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Pediatric Epilepsy Therapeutics Market Share by Type (2016-2027) Figure 30. Europe Pediatric Epilepsy Therapeutics Market Share by Application (2016-2027) Figure 31. Europe Pediatric Epilepsy Therapeutics Market Share by Country (2016-2027) Figure 32. Germany Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Pediatric Epilepsy Therapeutics Market Share by Type (2016-2027) Figure 40. Asia-Pacific Pediatric Epilepsy Therapeutics Market Share by Application (2016-2027) Figure 41. Asia-Pacific Pediatric Epilepsy Therapeutics Market Share by Region (2016-2027) Figure 42. China Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Pediatric Epilepsy Therapeutics Market Share by Type (2016-2027) Figure 50. Latin America Pediatric Epilepsy Therapeutics Market Share by Application (2016-2027) Figure 51. Latin America Pediatric Epilepsy Therapeutics Market Share by Country (2016-2027) Figure 52. Mexico Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Pediatric Epilepsy Therapeutics Market Share by Type (2016-2027) Figure 56. Middle East & Africa Pediatric Epilepsy Therapeutics Market Share by Application (2016-2027) Figure 57. Middle East & Africa Pediatric Epilepsy Therapeutics Market Share by Country (2016-2027) Figure 58. Turkey Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Pediatric Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Abbott Laboratories Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 62. GlaxoSmithKline Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 63. Cephalon Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 66. Sunovion Pharmaceuticals Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 67. Bausch Health Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 68. Sanofi Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Abbott Laboratories GlaxoSmithKline Cephalon Pfizer Novartis Sunovion Pharmaceuticals Bausch Health Sanofi